Overview

Resuscitative Endocrinology: Single-dose Clinical Uses for Estrogen-Traumatic Hemorrhagic Shock (RESCUE - Shock)

Status:
Completed

Trial end date:
2012-05-01

Target enrollment:

Participant gender:

Summary

Based on encouraging results from animal studies, the investigators hypothesize that early administration of IV Premarin® in patients with hemorrhagic shock will safely reduce secondary injury, and improve survival.

Phase:

Phase 2

Details

Lead Sponsor:

University of Texas Southwestern Medical Center

Collaborators:

Resuscitation Outcomes Consortium
University of Washington

Treatments:

Estrogens
Estrogens, Conjugated (USP)